Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in Subjects with SLE.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
NCT06875960 · Systemic Lupus Erythematosus (SLE), Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
NCT06647069 · Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA)
NCT06839976 · SLE, Systemic Lupus Erythematosus (SLE), and more
NCT07413341 · Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome (SS), and more
NCT07331272 · Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathies(IIM)
Wuhan Union Hospital
Wuhan, Hubei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions